EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Novel Index Consisting of Age, CA19 ‐9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer

Shoko Tabara, Yutaka Suehiro iD, Harumi Suehiro, Ukyo Shinagawa, Kaori Hamamoto, Takanori Tsuyama, Shuhei Shinoda iD, Shigeyuki Suenaga iD, Yuki Kunimune iD, Ikuei Fujii, Chieko Suzuki iD, Shingo Higaki und 2 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.72202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Shoko Tabara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Japan. Hauptthemen laut MEDLINE: Somatostatin, Pancreatic Neoplasms, CA-19-9 Antigen, Early Detection of Cancer. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are no reliable screening tests for pancreatic ductal adenocarcinoma (PDAC). We performed this study to address this issue. Using 206 serum samples from 95 healthy subjects and 111 patients with PDAC, we developed the novel ACAm‐S index, which consists of age, CA19‐9, and methylated somatostatin . The ACAm‐S index showed a sensitivity of 91.0% (101/111) for all stages of PDAC and a specificity of 94.7% (90/95). Notably, its sensitivity was high at 85.4% (35/41), even for Stage I PDAC. The ACAm‐S index may have potential as a blood‐based screening tool for early‐stage PDAC in the general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SomatostatinPancreatic NeoplasmsCA-19-9 AntigenEarly Detection of CancerCarcinoma, Pancreatic DuctalBiomarkers, TumorHumansFemaleMaleMiddle AgedAgedNeoplasm StagingAge FactorsAdult

Stichwörter der Autor:innen

carbohydrate antigen 19‐9liquid biopsymethylated somatostatinpancreatic ductal adenocarcinoma

Substanzen

SomatostatinCA-19-9 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Department of Health Screening, Ajisu Kyoritsu Hospital, Yamaguchi, Japan.
  • Department of Internal Medicine, Ajisu Kyoritsu Hospital, Yamaguchi, Japan.
  • Department of Gastroenterology, St. Hill Hospital, Ube, Japan.

ORCID-Profile: Yutaka Suehiro, Shuhei Shinoda, Shigeyuki Suenaga, Yuki Kunimune, Chieko Suzuki, Taro Takami, Takahiro Yamasaki

Förderung

  • JSPS KAKENHI

Zitieren

APA

Tabara, S., Suehiro, Y., Suehiro, H., Shinagawa, U., Hamamoto, K., Tsuyama, T., Shinoda, S., Suenaga, S., Kunimune, Y., Fujii, I., Suzuki, C., Higaki, S., Takami, T., & Yamasaki, T. (2026). A Novel Index Consisting of Age, CA19 ‐9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.72202

Vancouver

Tabara S, Suehiro Y, Suehiro H, Shinagawa U, Hamamoto K, Tsuyama T, et al. A Novel Index Consisting of Age, CA19 ‐9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer. Cancer Medicine. 2026. doi:10.1002/cam4.72202

BibTeX
@article{Tabara2026,
  author = {Tabara, Shoko and Suehiro, Yutaka and Suehiro, Harumi and Shinagawa, Ukyo and Hamamoto, Kaori and Tsuyama, Takanori and Shinoda, Shuhei and Suenaga, Shigeyuki and Kunimune, Yuki and Fujii, Ikuei and Suzuki, Chieko and Higaki, Shingo and Takami, Taro and Yamasaki, Takahiro},
  title = {A Novel Index Consisting of Age, CA19 ‐9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72202}
}
Kostenlos starten →